RxDoctor Payments Data

David Friedgood, DO

Neurology · Des Moines, IANPI 1134233794

Payments from drug & device makers

$647in general payments, 2019–2025

Across 41 payments — averaging $15.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$117
  • Teva Pharmaceuticals USA, Inc.$86
  • Amgen$56
  • Biogen$52
  • Supernus Pharmaceuticals, Inc.$45
  • EMD Serono, Inc.$32
  • plus $260 from 12 others

What the payments were for

  • Speaking & faculty fees$122%
  • Food & beverage$63498%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$647 in reported general payments places this provider in the 50th percentile of 132 neurology providers in Iowa.

See all neurology providers in Iowa

Medicare billing

Part B allowed, 2024
$11,205
Medicare patients
74
Services billed
113

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Primidone16$394

Paid to pharmacies, not to this prescriber.

Other neurology in Des Moines

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →